Barclays
NARI

Barclays’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Barclays’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-97,141
Closed -$4.96M – 5658
2024
Q4 		$4.96M Sell
97,141
-190,938
-66% -$9.39M ﹤0.01% 2183
2024
Q3 		$11.9M Buy
288,079
+25,365
+10% +$1.22M ﹤0.01% 1353
2024
Q2 		$12.6M Sell
262,714
-162,215
-38% -$7.19M ﹤0.01% 1102
2024
Q1 		$20.4M Buy
424,929
+306,994
+260% +$16.4M 0.01% 978
2023
Q4 		$7.66M Sell
117,935
-132,127
-53% -$7.96M ﹤0.01% 1734
2023
Q3 		$16.4M Buy
250,062
+9,318
+4% +$586K 0.01% 819
2023
Q2 		$14M Buy
240,744
+147,828
+159% +$9.32M 0.01% 851
2023
Q1 		$5.74M Buy
92,916
+71,940
+343% +$4.32M ﹤0.01% 1449
2022
Q4 		$1.33M Sell
20,976
-12,838
-38% -$931K ﹤0.01% 2570
2022
Q3 		$2.46M Buy
33,814
+20,230
+149% +$1.51M ﹤0.01% 1608
2022
Q2 		$924K Buy
13,584
+4,655
+52% +$335K ﹤0.01% 2428
2022
Q1 		$809K Buy
+8,929
New +$731K ﹤0.01% 2564

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $426M AUM 23.62% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Barclays's NARI Position: Q1 2025 in Review

Barclays sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 97,141 shares — an estimated $4.96M sold.

Barclays first reported a position in NARI in Q1 2022 and held it in 12 quarters. The position peaked at $20.4M in Q1 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Barclays reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Barclays sold 97,141 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $4.96M.
  • Barclays first reported a position in Inari Medical, Inc. Common Stock in Q1 2022 and held it in 12 quarters.
  • Barclays's Inari Medical, Inc. Common Stock position peaked at $20.4M in Q1 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.